The intestinal flora transplantation performed by our study group takes the form of clinical application by clinicians nationwide and is formally self-funded.<\/p>\r\n\r\n
HOWEVER, BECAUSE THE NEW TREATMENT METHOD OF INTESTINAL FLORA TRANSPLANTATION IS ATTRACTING A GREAT DEAL OF ATTENTION AROUND THE WORLD, AND IN THE UNITED STATES, IT HAS BEEN ESTABLISHED AS A TREATMENT METHOD RECOMMENDED BY PUBLIC INSTITUTIONS FOR SOME DISEASES, IT IS ASSUMED THAT INTESTINAL FLORA TRANSPLANTATION (FMT) WILL BE THE SUBJECT OF A CLINICAL RESEARCH METHOD IN THE NEAR FUTURE.<\/p>\r\n\r\n
Since its establishment, the Society has established and operated a system that conforms to the guidelines of the Clinical Research Act in the reporting of adverse events and the handling of patient information.<\/p>\r\n\r\n
Intestinal flora transplantation, which has not yet been established as a medicine, records as “adverse events” all deteriorations in health that occur after transplantation.<\/p>\r\n\r\n
Please see today’s update on the number of adverse event reports.<\/p>\r\n\r\n